AKT1 and hepatocellular carcinoma: Gal-1 overexpression induces EMT in HCC cell lines through the integrin/FAK/PI3K/AKT pathway (Fig. 5f) [127, 148], whereas Gal-1 inhibition suppresses EMT [127].